Literature DB >> 29706644

Distinct variants affecting differential splicing of TGFBR1 exon 5 cause either Loeys-Dietz syndrome or multiple self-healing squamous epithelioma.

Takayuki Fujiwara, Norifumi Takeda1, Hironori Hara2, Hiroyuki Morita2, Jun Kishihara3, Ryo Inuzuka4, Hiroki Yagi2, Sonoko Maemura2, Haruhiro Toko2, Mutsuo Harada2, Yuichi Ikeda2, Hidetoshi Kumagai2, Seitaro Nomura2, Eiki Takimoto2, Hiroshi Akazawa2, Junya Ako3, Issei Komuro2.   

Abstract

Variants in TGFBR1 have been reported to induce two completely distinct diseases, namely Loeys-Dietz syndrome (LDS) and multiple self-healing squamous epithelioma (MSSE). However, detailed mechanisms underlying this effect remain unknown. We report a Japanese familial case of LDS with a novel splice donor site variant in TGFBR1 gene (c.973 + 1 G > A; NG_007461.1). The intronic variant was predicted to mediate in-frame exon 5 skipping within the serine/threonine kinase (STK) domain, which may also be mediated by a similar TGFBR1 variant of a splice acceptor site in intron 4 (c.806-2 A > C), identified in a British familial case of MSSE. Therefore, ex vivo splicing and functional assays were performed in mammalian cells to evaluate the effect of these sequence variants. The MSSE variant activated a cryptic acceptor site at 76 bp downstream of the 3' natural splice acceptor site, which produced an out-of-frame transcript (r.807_882del, p.Asn270Thrfs*8). In contrast, the LDS variant generated two types of in-frame transcription products, r.[806_973del, 965_973 del], and produced two functionally inactivated proteins, p.[Asp269_Gln324del, Thr323_Gly325del], as a result of exon 5 skipping and the activation of a cryptic donor splice site at 9 bp upstream of the 5' natural splice donor site, respectively. Our results support the previously proposed but not yet approved mechanism that dominant-negative and truncating variants in STK domain induce LDS and MSSE, respectively.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29706644      PMCID: PMC6057981          DOI: 10.1038/s41431-018-0127-1

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

2.  Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.

Authors:  Yasuhiro Takeshima; Mariko Yagi; Yo Okizuka; Hiroyuki Awano; Zhujun Zhang; Yumiko Yamauchi; Hisahide Nishio; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2010-05-20       Impact factor: 3.172

3.  Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1.

Authors:  David R Goudie; Mariella D'Alessandro; Barry Merriman; Hane Lee; Ildikó Szeverényi; Stuart Avery; Brian D O'Connor; Stanley F Nelson; Stephanie E Coats; Arlene Stewart; Lesley Christie; Gabriella Pichert; Jean Friedel; Ian Hayes; Nigel Burrows; Sean Whittaker; Anne-Marie Gerdes; Sigurd Broesby-Olsen; Malcolm A Ferguson-Smith; Chandra Verma; Declan P Lunny; Bruno Reversade; E Birgitte Lane
Journal:  Nat Genet       Date:  2011-02-27       Impact factor: 38.330

4.  Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display.

Authors:  A F Muro; M Caputi; R Pariyarath; F Pagani; E Buratti; F E Baralle
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

6.  Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin.

Authors:  S J Robertson; S J Bashir; G Pichert; A Robson; S Whittaker
Journal:  Clin Exp Dermatol       Date:  2009-10-23       Impact factor: 3.470

7.  The paradoxical TGF-β vasculopathies.

Authors:  Rosemary J Akhurst
Journal:  Nat Genet       Date:  2012-07-27       Impact factor: 38.330

8.  A deleterious MYH11 mutation causing familial thoracic aortic dissection.

Authors:  Norifumi Takeda; Hiroyuki Morita; Daishi Fujita; Ryo Inuzuka; Yuki Taniguchi; Kan Nawata; Issei Komuro
Journal:  Hum Genome Var       Date:  2015-08-06

9.  Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertension.

Authors:  Hironori Hara; Norifumi Takeda; Hiroyuki Morita; Masaru Hatano; Eisuke Amiya; Hisataka Maki; Shun Minatsuki; Mizuri Taki; Yasuyuki Shiraishi; Takayuki Fujiwara; Sonoko Maemura; Issei Komuro
Journal:  Hum Genome Var       Date:  2017-04-20

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  8 in total

1.  Association of gene polymorphisms in MYH11 and TGF-β signaling with the susceptibility and clinical outcomes of DeBakey type III aortic dissection.

Authors:  Yafei Chang; Qinghua Yuan; Yitong Ma; Xiang Ma; Peipei Jiang; Ling Sun
Journal:  Mamm Genome       Date:  2021-11-02       Impact factor: 3.224

2.  Application of CRISPR-Cas9 gene editing for congenital heart disease.

Authors:  Heeyoung Seok; Rui Deng; Douglas B Cowan; Da-Zhi Wang
Journal:  Clin Exp Pediatr       Date:  2021-03-02

3.  Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome.

Authors:  Hironori Hara; Sonoko Maemura; Takayuki Fujiwara; Norifumi Takeda; Satoshi Ishii; Hiroki Yagi; Takaaki Suzuki; Mutsuo Harada; Haruhiro Toko; Tsubasa Kanaya; Hideaki Ijichi; Harold L Moses; Eiki Takimoto; Hiroyuki Morita; Hiroshi Akazawa; Issei Komuro
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

Review 4.  Multiple Self-Healing Squamous Epithelioma (MSSE): A Digenic Trait Associated with Loss of Function Mutations in TGFBR1 and Variants at a Second Linked Locus on the Long Arm of Chromosome 9.

Authors:  David Goudie
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

5.  Germline Mutations for Kidney Volume in ADPKD.

Authors:  Hiroshi Kataoka; Rie Yoshida; Naomi Iwasa; Masayo Sato; Shun Manabe; Keiko Kawachi; Shiho Makabe; Taro Akihisa; Yusuke Ushio; Atsuko Teraoka; Ken Tsuchiya; Kosaku Nitta; Toshio Mochizuki
Journal:  Kidney Int Rep       Date:  2021-12-13

Review 6.  Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders.

Authors:  Jennie Vagher; Amanda Gammon; Wendy Kohlmann; Joanne Jeter
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

Review 7.  TGF-β Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections.

Authors:  Norifumi Takeda; Hironori Hara; Takayuki Fujiwara; Tsubasa Kanaya; Sonoko Maemura; Issei Komuro
Journal:  Int J Mol Sci       Date:  2018-07-21       Impact factor: 5.923

8.  Activation of TGF-β signaling in an aortic aneurysm in a patient with Loeys-Dietz syndrome caused by a novel loss-of-function variant of TGFBR1.

Authors:  Hironori Hara; Norifumi Takeda; Takayuki Fujiwara; Hiroki Yagi; Sonoko Maemura; Tsubasa Kanaya; Kan Nawata; Hiroyuki Morita; Issei Komuro
Journal:  Hum Genome Var       Date:  2019-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.